The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Canfield Scientific sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Canfield Scientific is a biotechnology company that provides imaging systems and related services for research and healthcare markets. It offers products for scientific research and healthcare applications, including the biotechnology, cosmetics, pharmaceutical, medical and skin care industries. The company major products include Vectra H2, IntelliStudio, VISIA, Reveal, Luminis and others. Canfield also provides clinical services including integrated solutions; image analysis; graphic services; and data management. It operates in Germany, Netherlands, Denmark, Greece, Finland, Italy, France, Norway, Australia and others. Canfield is headquartered in Parsippany, New Jersey, the US.
The key metrics of Canfield Scientific related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Canfield Scientific is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Canfield Scientific.
For a detailed understanding of the performance of Canfield Scientific, buy the report here.